Registry for patients at high risk for pancreatic cancer
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mayo Clinic · NCT06151223
This study is creating a registry for people at high risk of pancreatic cancer to see if new tests can help catch the disease early.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT06151223 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a registry for individuals at high risk of developing pancreatic ductal adenocarcinoma (PDAC). It focuses on the discovery and validation of early detection tests and employs advanced machine learning algorithms to analyze databases and images for identifying early stages of pancreatic cancer. The study will also facilitate the development of interventional protocols aimed at early detection of PDAC. Participants will undergo bio-specimen collection and MRI to support these objectives.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and older who meet the criteria for being high-risk for pancreatic cancer.
Not a fit: Patients with a personal history of pancreatic ductal adenocarcinoma or those who have undergone total pancreatectomy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier detection of pancreatic cancer, improving treatment outcomes for high-risk patients.
How similar studies have performed: Other studies have shown promise in using machine learning for early detection of cancers, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 year * Able to provide written informed consent * Meets criteria as a High-Risk Individual as defined by protocol Exclusion Criteria: * Individual who has a personal history of pancreatic ductal adenocarcinoma (PDAC) * History of total pancreatectomy
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Shounak Majumder, M.D. — Mayo Clinic in Rochester
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma